Danish devices association urges authorities to deter reuse firm
This article was originally published in Clinica
Denmark's state serum institute (SSI) has denied suggestions that it has in any way approved the practices of German medical devices reprocessing company Vanguard. This statement comes despite the publication of a report by SSI in which it claims that the resterilisation of single-use devices is defensible "in certain cases". In reply to a letter from Medicoidustrien, the medical devices industry association, SSI said that it did not even have the authority to approve such procedures.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.